Anna Berkenblit is a seasoned biotech executive and oncologist currently serving as the Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network and as an Independent Board Director at Nested Therapeutics and Surrozen. They previously held the role of SVP and Chief Medical Officer at ImmunoGen, Inc., and contributed to significant clinical development efforts for various oncology compounds at AVEO and Pfizer. With a Master of Medical Sciences from Harvard-MIT, Anna has dedicated their career to advancing cancer treatments and leading clinical research initiatives in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices